Suven Life Sciences Limited Sustainability Profile
Suven Life Sciences Limited, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in drug discovery and development, focusing on central nervous system disorders and other therapeutic areas. With a robust portfolio of innovative products and services, Suven Life Sciences is renowned for its unique approach to developing novel compounds that address unmet medical needs. The company has achieved significant milestones, including successful collaborations and partnerships that enhance its market position. Operating primarily in India and expanding its reach globally, Suven Life Sciences continues to make strides in the industry, driven by a commitment to research excellence and patient-centric solutions.
DitchCarbon Score
How does Suven Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suven Life Sciences Limited's score of 24 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Suven Life Sciences Limited's reported carbon emissions
In 2024, Suven Life Sciences Limited reported total carbon emissions of approximately 915,600 kg CO2e, comprising about 32,090 kg CO2e from Scope 1 and about 883,510 kg CO2e from Scope 2 emissions. In 2023, the company’s emissions were slightly lower, with total emissions of about 888,620 kg CO2e, including approximately 30,540 kg CO2e from Scope 1 and about 858,080 kg CO2e from Scope 2. The emissions data for 2022 also reflects a similar trend, with total emissions of about 890,219 kg CO2e, consisting of approximately 31,101 kg CO2e from Scope 1 and about 859,118 kg CO2e from Scope 2. Suven Life Sciences Limited has not disclosed any specific reduction targets or initiatives as part of its climate commitments. The company operates as a current subsidiary and does not inherit any emissions data from a parent organization. The absence of Scope 3 emissions data indicates a potential area for future reporting and improvement. Overall, while Suven Life Sciences Limited has made strides in tracking its carbon emissions, the lack of defined reduction targets suggests an opportunity for the company to enhance its climate strategy and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 31,101 | 00,000 | 00,000 |
| Scope 2 | 859,118 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Suven Life Sciences Limited's Industry?
How Carbon Intensive is Suven Life Sciences Limited's Location?
Suven Life Sciences Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Suven Life Sciences Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
